PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsMarinus Pharmaceuticals
Marinus Pharmaceuticals(MRNS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
ZtalmyGanaxolone2023-07-262026-2037
Infantile spasms
,
Seizures
,
Epileptic syndromes
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ganaxolone
pregnancy complications
,
postpartum depression
,
puerperal disorders
,
depression
,
mood disorders
,
mental disorders
,
depressive disorder
,
behavioral symptoms
,
partial epilepsies
,
spasm
,
infantile spasms
,
postpartum period
,
fragile x syndrome
,
syndrome
,
post-traumatic stress disorders
,
traumatic stress disorders
,
complex partial epilepsy
,
muscle cramp
,
epilepsy
,
status epilepticus
,
seizures
,
tuberous sclerosis
,
sclerosis
,
drug resistant epilepsy
Alfacalcidol
type 2 diabetes mellitus
,
psoriatic arthritis
Lotamilast
respiratory tract infections
,
infections
,
sinusitis
,
bronchitis
,
rhinosinusitis
Remetinostat
healthy volunteers/patients
,
agnosia
,
pain
,
bone fractures
,
acute pain
Sepranolone
alcoholism
,
dementia
,
cognitive dysfunction
,
parkinson disease
,
epilepsy
,
alzheimer disease
,
traumatic brain injuries
,
major depressive disorder
,
mood disorders
,
seizures
,
post-traumatic stress disorders
,
wounds and injuries
,
brain injuries
,
healthy volunteers/patients
,
anxiety disorders
,
ataxia
,
tremor
,
fragile x syndrome
,
cerebellar ataxia
,
neurodegenerative diseases
,
pharmacogenomic testing
,
migraine disorders
,
pain
,
chronic pain
,
low back pain
,
post-traumatic epilepsy
,
complex partial epilepsy
,
tourette syndrome
,
tinnitus
,
stroke
,
syndrome
,
covid-19
,
respiratory distress syndrome
,
acute lung injury
,
newborn respiratory distress syndrome
,
depression
,
depressive disorder
,
premenstrual syndrome
,
premenstrual dysphoric disorder
,
postpartum depression
,
treatment-resistant depressive disorder
,
smoking cessation
Usistapide
liver failure
,
hepatic insufficiency
,
renal insufficiency
,
hypertension
,
hepatitis c
,
hepatitis
,
hepatitis a
,
neoplasms
,
overactive urinary bladder
,
parkinson disease
,
central nervous system diseases
,
brain diseases
,
movement disorders
,
neurodegenerative diseases
,
head and neck neoplasms
,
cough
,
schizophrenia
,
nervous system diseases
,
carcinoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
squamous cell neoplasms
,
leukemia
,
myelodysplastic syndromes
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia
,
preleukemia
,
blast crisis
,
lymphoid leukemia
,
melanoma
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
esophageal neoplasms
,
panic disorder
,
alcoholism
,
postoperative pain
,
osteoarthritis
,
neuralgia
,
postherpetic neuralgia
,
general anesthesia
,
glioblastoma
,
astrocytoma
,
anesthesia
,
muscle relaxation
,
delayed emergence from anesthesia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use